Literature DB >> 15114022

Mouse models for studying orthopoxvirus respiratory infections.

Jill Schriewer1, R Mark L Buller, Gelita Owens.   

Abstract

Concern regarding the use of variola and monkeypox viruses as bioterrorist agents has led to an increased study of orthopoxviruses to understand the molecular and cellular basis of pathogenesis and develop safe and effective antivirals and vaccines against smallpox. Crucial to these efforts is the availability of animal models, which are inexpensive, genetically homogeneous, and recapitulate the human disease. The popular small-animal orthopoxvirus models employ the inbred mouse as the host, the respiratory tract as the site of virus inoculation, and orthopoxviruses-vaccinia, cowpox, and ectromelia viruses-as surrogates for variola virus. Ectromelia virus is likely the best surrogate for variola virus in a mouse model, as it is infectious at very low doses of virus, and the mousepox disease is associated with high mortality in the susceptible A, BALB/c, and DBA/2 stains of mice, but causes an unapparent infection in the C57BL/6 mouse strain. This chapter describes an ectromelia virus respiratory infection model in the mouse.

Entities:  

Mesh:

Year:  2004        PMID: 15114022     DOI: 10.1385/1-59259-789-0:289

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

Review 1.  The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model data.

Authors:  M Shannon Keckler; Mary G Reynolds; Inger K Damon; Kevin L Karem
Journal:  Vaccine       Date:  2013-08-27       Impact factor: 3.641

2.  Investigations of TB vaccine-induced mucosal protection in mice.

Authors:  Azra Blazevic; Christopher S Eickhoff; Jaime Stanley; Mark R Buller; Jill Schriewer; Eric M Kettelson; Daniel F Hoft
Journal:  Microbes Infect       Date:  2013-10-08       Impact factor: 2.700

3.  A homolog of the variola virus B22 membrane protein contributes to ectromelia virus pathogenicity in the mouse footpad model.

Authors:  Sara E Reynolds; Patricia L Earl; Mahnaz Minai; Ian Moore; Bernard Moss
Journal:  Virology       Date:  2016-11-26       Impact factor: 3.616

4.  Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection.

Authors:  Georges Abboud; Vikas Tahiliani; Pritesh Desai; Kyle Varkoly; John Driver; Tarun E Hutchinson; Shahram Salek-Ardakani
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

5.  CD8 T cells are essential for recovery from a respiratory vaccinia virus infection.

Authors:  John Goulding; Rebecka Bogue; Vikas Tahiliani; Michael Croft; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2012-07-23       Impact factor: 5.422

Review 6.  Smallpox vaccines: targets of protective immunity.

Authors:  Bernard Moss
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

7.  CD8 T cells use IFN-γ to protect against the lethal effects of a respiratory poxvirus infection.

Authors:  John Goulding; Georges Abboud; Vikas Tahiliani; Pritesh Desai; Tarun E Hutchinson; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2014-04-18       Impact factor: 5.422

8.  Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations.

Authors:  M B Townsend; M S Keckler; N Patel; D H Davies; P Felgner; I K Damon; K L Karem
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

9.  Experimental infection of cynomolgus macaques (Macaca fascicularis) with aerosolized monkeypox virus.

Authors:  Aysegul Nalca; Virginia A Livingston; Nicole L Garza; Elizabeth E Zumbrun; Ondraya M Frick; Jennifer L Chapman; Justin M Hartings
Journal:  PLoS One       Date:  2010-09-20       Impact factor: 3.240

10.  Dynamics of Pathological and Virological Findings During Experimental Calpox Virus Infection of Common Marmosets (Callithrix jacchus).

Authors:  Anne Schmitt; Li Lin Gan; Ahmed Abd El Wahed; Tingchuan Shi; Heinz Ellerbrok; Franz-Josef Kaup; Christiane Stahl-Hennig; Kerstin Mätz-Rensing
Journal:  Viruses       Date:  2017-11-28       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.